Intro
Three markers live next to each other on modern lipid panels, and they are routinely confused for one another.
VLDL. Triglycerides. ApoB.
They are sometimes discussed as if they were measuring the same thing. They are sometimes presented as competing alternatives. ApoB, in particular, has been promoted in recent years as a more sophisticated replacement for the older lipid markers, with the implication that the others are no longer needed.
None of those framings is quite right.
The three markers are not redundant, and they are not in competition. They are answering three different questions about the same lipid system. Once that is clear, choosing what to look at — and how to interpret what you see — becomes much simpler.
---
Triglycerides Measure the Cargo
The triglyceride number on a lab panel tells you how much fat is currently in transit through circulation.
That is a useful thing to know. It is also a limited thing to know.
The triglycerides being measured can be coming from several sources. After a meal, they are largely riding on chylomicrons — particles produced by the intestine to transport dietary fat. In the fasted state, they are largely riding on VLDL — particles produced by the liver. As particles are remodeled in circulation, the triglycerides redistribute among intermediate forms.
The triglyceride number does not distinguish among these sources. It is a measurement of the cargo, not of the carrier.
This is why the standard criticism of triglycerides — that they are noisy, diet-dependent, and hard to interpret — has a real point. Measured in isolation, the triglyceride number cannot tell you what is producing the cargo or what is happening to it.
What it can do is show you the size of the pool. That is informative when read in context with the other markers, and especially in context with the question of what the liver is contributing to that pool.
---
VLDL Measures the Liver's Export Activity
VLDL is the carrier the liver builds and releases. When derived cleanly — by subtracting a directly measured LDL-C and HDL-C from total cholesterol, as discussed in the second post of this series — VLDL-C isolates the hepatic contribution to the triglyceride-rich lipoprotein pool.
That isolation is what makes VLDL the function marker.
Triglycerides tell you about the cargo from any source. VLDL tells you about the cargo the liver is specifically exporting. The difference matters, because the question of what the liver is doing is the question this entire series has been asking.
VLDL is not a refinement of triglycerides. It is a different measurement, answering a different question. When the question is "how much fat is in transit," triglycerides are the right number. When the question is "what is the liver doing," VLDL is the right number.
For the framework this series has been building, VLDL is the marker that matters most.
---
ApoB Measures the Total Particle Burden
Every atherogenic lipoprotein particle — VLDL, IDL, LDL, Lp(a) — carries exactly one apolipoprotein B-100. Measuring ApoB therefore counts the total number of these particles in circulation, regardless of how much cholesterol or triglyceride each one happens to be carrying.
This is what cardiology has correctly recognized as a more accurate atherogenic risk marker than LDL-C alone. Two patients with identical LDL-C values can carry very different numbers of LDL particles, and the patient with more particles is at higher risk. ApoB captures that difference. It tells you the total particle pressure being exerted on the artery wall.
ApoB is genuinely useful, and the cardiology field has been right to elevate it.
But it is important to be clear about what ApoB is measuring. It measures the consequence side of the lipid system — the total atherogenic particle burden. It does not measure the cause side — the upstream hepatic state that determined how many particles got produced in the first place.
VLDL and ApoB are not in competition. They are looking at different parts of the same process. VLDL looks at what the liver is exporting. ApoB looks at what is then circulating in the atherogenic pool. A complete reading of a lipid panel is informed by both.
---
How the Three Markers Relate
The cleanest way to state the relationship is this.
Triglycerides tell you about the cargo currently in transit.
VLDL tells you about the liver's contribution to that cargo, and therefore about the liver's recent operating state.
ApoB tells you about the total number of atherogenic particles in circulation, and therefore about the total particle pressure on the artery.
Three different angles on the same lipid system. None replaces the others. Each answers a different question.
When the markers move together — triglycerides up, VLDL up, ApoB up — they are reinforcing the same story from three angles. When they move apart — for example, an elevated ApoB with normal triglycerides and modest VLDL, suggesting a particle-quantity issue without active hepatic export overdrive — the divergence is itself information.
There is one divergence pattern in particular that deserves attention, because it is the easiest to miss.
A patient may have clear signs of hepatic stress — elevated triglycerides, hepatic steatosis on imaging, insulin resistance, the broader metabolic picture — but a VLDL number that is only modestly elevated, or even sitting inside the conventional reference range. Read in isolation, that VLDL number can look reassuring. Read in context, it is telling a different story.
A liver that is overloaded with substrate but unable to assemble and export VLDL particles cleanly will sometimes produce a quieter VLDL signal than the underlying hepatic state would predict. The lipid that should have been exported stays behind in the organ. The number on the panel reflects what got out, not what the liver was trying to send. As we discussed in the post on integration, part of what VLDL reports, in cases like this, is the export failure itself.
The clinical implication is straightforward. A modest VLDL in a patient with hepatic steatosis and elevated triglycerides should not be read as good news. It should be read as a reason to look more carefully at what the liver is being asked to do, and at whether it has what it needs to do that work cleanly.
---
Which One to Look at, and When
For the question this series has been asking — what is the liver doing — VLDL is the marker. Derived cleanly from a directly measured LDL-C, it gives the most direct readout of hepatic export activity available on a standard panel.
For the question of total atherogenic particle burden — particularly in patients where the cardiology question is paramount — ApoB adds information that LDL-C alone cannot provide.
For the question of what is currently in transit — useful in the context of recent dietary patterns, post-prandial measurement, or specific clinical concerns about pancreatitis at very high values — triglycerides remain the right number.
Most patients benefit from looking at all three, in conversation with one another. The combination tells a more complete story than any one marker alone, and the three together let you see the system from cause to consequence.
The next and final post will close the series with what to do once VLDL is telling you something. Not a prescription, but a posture — and the practical first steps that follow from it.